Newswise News from University of Kansas Cancer Center Latest news from University of Kansas Cancer Center on Newswise en-us Copyright 2024 Newswise Newswise News from University of Kansas Cancer Center 115 31 / /images/newswise-logo-rss.gif New Study Aims to Improve Bladder Cancer Treatment with High-Dose Intravenous Vitamin C /articles/new-study-aims-to-improve-bladder-cancer-treatment-with-high-dose-intravenous-vitamin-c/?sc=rsin /articles/new-study-aims-to-improve-bladder-cancer-treatment-with-high-dose-intravenous-vitamin-c/?sc=rsin Mon, 12 Aug 2024 11:05:58 EST Researchers at The University of Kansas Cancer Center have secured a $3.6 million grant from the U.S. Department of Defense to study high-dose intravenous Vitamin C for treating muscle-invasive bladder cancer. This type of cancer occurs when cancer cells spread to the muscle layer of the bladder wall. University of Kansas Cancer Center Anthony Sung, MD, named director of Center for Survivorship and Patient-Oriented Research /articles/anthony-sung-md-named-director-of-center-for-survivorship-and-patient-oriented-research/?sc=rsin /articles/anthony-sung-md-named-director-of-center-for-survivorship-and-patient-oriented-research/?sc=rsin Tue, 23 Jul 2024 09:05:26 EST Anthony Sung, MD, has been named the A. Drue Jennings Professor in Medical Oncology and the director of the Center for Survivorship and Patient-Oriented Research at The University of Kansas Cancer Center. University of Kansas Cancer Center NIH renews COBRE grant for Kansas Institute for Precision Medicine /articles/nih-renews-cobre-grant-for-kansas-institute-for-precision-medicine/?sc=rsin /articles/nih-renews-cobre-grant-for-kansas-institute-for-precision-medicine/?sc=rsin Tue, 14 May 2024 13:05:59 EST The Kansas Institute for Precision Medicine (KIPM) will continue its mission to improve health care by training physicians and scientists in precision medicine and supporting their research, thanks to a renewed Centers of Biomedical Research Excellence (COBRE) award from the National Institute of General Medical Sciences, part of the National Institutes of Health. University of Kansas Cancer Center KU Cancer Center Researcher Secures $1.4M Grant to Develop Peptide Therapy for Prostate Cancer /articles/ku-cancer-center-researcher-secures-1-4m-grant-to-develop-peptide-therapy-for-prostate-cancer/?sc=rsin /articles/ku-cancer-center-researcher-secures-1-4m-grant-to-develop-peptide-therapy-for-prostate-cancer/?sc=rsin Fri, 29 Mar 2024 11:05:54 EST Benyi Li, MD, PhD, professor in the Department of Urology and member of The University of Kansas Cancer Center, has received a nearly $1.4 million grant from the U.S. Department of Defense to develop a short peptide-based therapy for prostate cancer patients. University of Kansas Cancer Center Pool Cool Makes Fun in the Sun Safe /articles/pool-cool-makes-fun-in-the-sun-safe/?sc=rsin /articles/pool-cool-makes-fun-in-the-sun-safe/?sc=rsin Mon, 04 Mar 2024 15:05:21 EST Pool Cool is a program designed to educate young people in The University of Kansas Cancer Center's catchment area on sun safety behaviors. University of Kansas Cancer Center Researchers Look at Ways to Target Early Breast Cancer Progression /articles/researchers-look-at-ways-to-target-early-breast-cancer-progression/?sc=rsin /articles/researchers-look-at-ways-to-target-early-breast-cancer-progression/?sc=rsin Thu, 22 Feb 2024 15:05:38 EST A researcher at The University of Kansas Cancer Center has received a $930,000 grant from the U.S. Department of Defense to study a new targeted therapy option for people diagnosed with ductal carcinoma in situ (DCIS). University of Kansas Cancer Center KU Cancer Center receives $2.4 million grant to foster the next generation of translational scientists /articles/ku-cancer-center-receives-2-4-million-grant-to-foster-the-next-generation-of-translational-scientists/?sc=rsin /articles/ku-cancer-center-receives-2-4-million-grant-to-foster-the-next-generation-of-translational-scientists/?sc=rsin Tue, 24 Oct 2023 15:05:05 EST In order to grow and train future clinical and translational scientists, The University of Kansas Cancer Center has received a $2.4 million grant from the National Cancer Institute (NCI). University of Kansas Cancer Center KU Cancer Center receives historic $100 million gift from Sunderland Foundation to support new cancer research and care facility /articles/the-university-of-kansas-cancer-center-receives-historic-100-million-lead-gift-to-support-transformative-new-cancer-research-and-care-facility/?sc=rsin /articles/the-university-of-kansas-cancer-center-receives-historic-100-million-lead-gift-to-support-transformative-new-cancer-research-and-care-facility/?sc=rsin Tue, 27 Jun 2023 21:05:58 EST The University of Kansas Cancer Center has received a $100 million lead gift to build a new, state-of-the-art destination cancer center. This gift is both the largest gift ever given by the Sunderland Foundation and the largest ever received by the University of Kansas and The University of Kansas Health System. University of Kansas Cancer Center Optimizing the Immune System to Beat Cancer /articles/optimizing-the-immune-system-to-beat-cancer/?sc=rsin /articles/optimizing-the-immune-system-to-beat-cancer/?sc=rsin Wed, 31 May 2023 14:55:42 EST Chimeric antigen receptor (CAR) T-cell therapy amplifies the immune system's ability to recognize and kill cancer cells. The first CAR T-cell therapy was approved by the Food and Drug Administration (FDA) in 2017. Today, there are 6 FDA-approved CAR-based therapies to treat certain types of leukemia, lymphoma and myeloma, all of which are available at The University of Kansas Cancer Center. University of Kansas Cancer Center KU Cancer Center uses art to reach underserved communities /articles/ku-cancer-center-uses-art-to-reach-underserved-communities/?sc=rsin /articles/ku-cancer-center-uses-art-to-reach-underserved-communities/?sc=rsin Thu, 23 Feb 2023 16:35:53 EST The mural, designed in collaboration with members of organizations in the surrounding urban community, is one part of the The University of Kansas Cancer Center's broader campaign to increase the participation of minority and underserved populations in clinical trials. University of Kansas Cancer Center KU Medical Center researchers receive R01 grant from National Cancer Institute to increase targeted cancer treatments to rural cancer patients /articles/ku-medical-center-researchers-receive-r01-grant-from-national-cancer-institute-to-increase-targeted-cancer-treatments-to-rural-cancer-patients/?sc=rsin /articles/ku-medical-center-researchers-receive-r01-grant-from-national-cancer-institute-to-increase-targeted-cancer-treatments-to-rural-cancer-patients/?sc=rsin Wed, 16 Nov 2022 14:40:05 EST TEAMSPORT will create a standardized approach to ordering genomic tests and adapt it for use in community cancer centers, where most cancer patients receive testing and treatment. University of Kansas Cancer Center The University of Kansas Cancer Center Partners with Nation's Top Cancer Organizations to Endorse Initiative to Increase Lung Cancer Screening in the United States /articles/the-university-of-kansas-cancer-center-partners-with-nation-s-top-cancer-organizations-to-endorse-initiative-to-increase-lung-cancer-screening-in-the-united-states/?sc=rsin /articles/the-university-of-kansas-cancer-center-partners-with-nation-s-top-cancer-organizations-to-endorse-initiative-to-increase-lung-cancer-screening-in-the-united-states/?sc=rsin Tue, 01 Nov 2022 09:45:18 EST Joint call to action urges individuals, providers and insurers to increase access to and utilization of low-dose CT screening for those at high risk for lung cancer. University of Kansas Cancer Center Kansas Governor issues proclamation to honor The University of Kansas Cancer Center's earning highest designation from the National Cancer Institute /articles/kansas-governor-issues-proclamation-to-honor-the-university-of-kansas-cancer-center-s-earning-highest-designation-from-the-national-cancer-institute/?sc=rsin /articles/kansas-governor-issues-proclamation-to-honor-the-university-of-kansas-cancer-center-s-earning-highest-designation-from-the-national-cancer-institute/?sc=rsin Thu, 01 Sep 2022 21:05:56 EST Kansas Governor Laura Kelly has proclaimed September "Comprehensive Cancer Centers Awareness Month" in recognition of The University of Kansas Cancer Center becoming designated as a "Comprehensive" cancer center by the National Cancer Institute (NCI). University of Kansas Cancer Center KU Cancer Center researchers discover that people with blood-related cancers have a higher chance of COVID breakthrough infections /articles/ku-cancer-center-researchers-discover-that-people-with-blood-related-cancers-have-a-higher-chance-of-covid-breakthrough-infections/?sc=rsin /articles/ku-cancer-center-researchers-discover-that-people-with-blood-related-cancers-have-a-higher-chance-of-covid-breakthrough-infections/?sc=rsin Fri, 12 Aug 2022 09:30:47 EST Individuals with blood-related cancers are more likely to experience a COVID-19 infection even after being vaccinated, a University of Kansas Cancer Center study has found. University of Kansas Cancer Center The University of Kansas Cancer Center earns National Cancer Institute's most prestigious status --Comprehensive /articles/headline4/?sc=rsin /articles/headline4/?sc=rsin Thu, 07 Jul 2022 10:30:44 EST The University of Kansas Cancer Center has been designated as a "Comprehensive" cancer center by the National Cancer Institute (NCI). This is the highest level of recognition awarded by the NCI and is the gold standard for cancer centers. University of Kansas Cancer Center Varenicline Increases Smoking Cessation Rates for African American Smokers /articles/varenicline-increases-smoking-cessation-rates-for-african-american-smokers/?sc=rsin /articles/varenicline-increases-smoking-cessation-rates-for-african-american-smokers/?sc=rsin Tue, 14 Jun 2022 13:05:42 EST Researchers at The University of Kansas Cancer Center have released the results of a clinical trial that examined the effectiveness of varenicline in African Americans. In their study published in JAMA, African American daily smokers who were given varenicline while receiving counseling had significantly greater quit rates than those who received a placebo. University of Kansas Cancer Center COVID-19 Vaccine Effective in People Receiving Cancer Treatment, Study Finds /articles/covid-19-vaccine-effective-in-people-receiving-cancer-treatment-study-finds/?sc=rsin /articles/covid-19-vaccine-effective-in-people-receiving-cancer-treatment-study-finds/?sc=rsin Wed, 11 May 2022 12:15:48 EST About 95% of participants achieved a measurable immune response after vaccination, according to study published in JAMA Oncology. University of Kansas Cancer Center Targeting Triple-Negative Breast Cancer /articles/targeting-triple-negative-breast-cancer/?sc=rsin /articles/targeting-triple-negative-breast-cancer/?sc=rsin Mon, 28 Feb 2022 12:05:45 EST A three-year $1.2 million Breakthrough Award grant from the Department of Defense will help researchers identify tailored treatments for people with triple-negative breast cancer. Priyanka Sharma, MD, breast medical oncologist, and Shane Stecklein, MD, PhD, radiation oncologist, will lead the project. University of Kansas Cancer Center KU Clinical Research Center celebrates decade of investigational science /articles/ku-clinical-research-center-celebrates-decade-of-investigational-science/?sc=rsin /articles/ku-clinical-research-center-celebrates-decade-of-investigational-science/?sc=rsin Wed, 26 Jan 2022 11:40:24 EST Ten years ago, on Jan. 23, 2012, the brand-new University of Kansas Clinical Research Center opened its doors. University of Kansas Cancer Center Receiving CAR-T therapy sooner improves lymphoma survival, according to study published in New England Journal of Medicine /articles/receiving-car-t-therapy-sooner-improves-lymphoma-survival-according-to-study-published-in-new-england-journal-of-medicine/?sc=rsin /articles/receiving-car-t-therapy-sooner-improves-lymphoma-survival-according-to-study-published-in-new-england-journal-of-medicine/?sc=rsin Fri, 17 Dec 2021 16:15:59 EST Axicabtagene ciloleucel, known by the brand name Yescarta, is significantly more effective than the current standard of care in treating people with large B-cell lymphoma who relapse after the first line of treatment. University of Kansas Cancer Center